
Intelligent Bio Solutions
(NASDAQ) INBS
Intelligent Bio Solutions Financials at a Glance
Market Cap
$5.49M
Revenue (TTM)
$3.91M
Net Income (TTM)
-$11.61M
EPS (TTM)
-$12.32
P/E Ratio
-0.19
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$2.20
Volume
66,077
Open
$2.27
Price
$2.20
Volume
66,077
Open
$2.27
Previous Close
$2.20
Daily Range
$2.18 - $2.31
52-Week Range
$2.18 - $24.90
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$2.20
Volume
66,077
Open
$2.27
Previous Close
$2.20
Daily Range
$2.18 - $2.31
52-Week Range
$2.18 - $24.90
Estimated Earnings Date
Aug 14, 2026
INBS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Intelligent Bio Solutions
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
55
CEO
Harry Simeonidis
Website
ibs.incHeadquarters
New York City, NY 10019, US
INBS Financials
Key Financial Metrics (TTM)
Gross Margin
32.08%
Operating Margin
-300.26%
Net Income Margin
-296.76%
Return on Equity
-174.16%
Return on Capital
-324.73%
Return on Assets
-78.13%
Earnings Yield
-5.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.49M
Shares Outstanding
2.39M
Volume
66.08K
Avg. Volume
121.25K
Financials (TTM)
Gross Profit
$1.26M
Operating Income
-$11.75M
EBITDA
-$10.40M
Operating Cash Flow
-$11.10M
Capital Expenditure
-$336.04K
Free Cash Flow
-$11.44M
Cash & ST Invst.
$6.86M
Total Debt
$1.85M
Intelligent Bio Solutions Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.06M
+45.5%
Gross Profit
$244.99K
+522.0%
Gross Margin
23.09%
N/A
Market Cap
$5.49M
N/A
Market Cap/Employee
$109.79K
N/A
Employees
50
N/A
Net Income
-$2.86M
-12.5%
EBITDA
-$2.58M
-15.3%
Quarterly Fundamentals
Total Cash
$6.86M
+144.5%
Total Debt
$1.85M
+261.6%
Accounts Receivable
$1.45M
+40.3%
Inventory
$597.47K
-12.6%
Long Term Debt
$1.46M
+39308.2%
Short Term Debt
$388.75K
-23.4%
Return on Assets
-78.13%
N/A
Return on Invested Capital
-1.15%
N/A
Free Cash Flow
-$4.47M
-61.3%
Operating Cash Flow
-$4.48M
-62.6%